INTRODUCTION
Although organic and inorganic arsenic containing compounds are environmental toxins, they are used for over 100 years for the treatment of human diseases 1,2 . Salvarsan, active against syphilis 3 , or melarsoprol, still used for the treatment of African sleeping sickness 4 , are examples for organic arsenicals. Fowler´s solution, which was used for the treatment of chronic myeloid leukemia (CML; Ref. 5) or psoriasis 6 , is an example for inorganic arsenic.
Most of these drugs have been replaced by others, as it became clear that arsenic causes diverse pathologies and increases the risk of cancer 7, 8 . Since the discovery that arsenic Depending on the cell type and the applied concentrations of arsenic, diverse cellular effects are observed (for a recent review see Ref. 12) . Low concentrations can induce differentiation or cell cycle arrest, whereas high concentrations can induce apoptosis. Mechanisms leading to induction of apoptosis were extensively studied. An important role was attributed to arsenic triggered degradation of specific proteins with pro-survival function. The strongest correlation was found with the degradation of the PML/RAR-protein in APL 13 , but also degradation of the viral Tax protein in HTLV-induced T-cell leukemia has been reported 14 . However, these mechanisms can not explain the induction of apoptosis in many other cell types. As a general finding, all three groups of MAPK, ERK, p38 and JNK, are activated in response to arsenic 15, 16 . This activation may be responsible for the carcinogenic effects of arsenic, but MAPK activation is not required for arsenic induced apoptosis 17 . Furthermore, the The aim of our study was to investigate whether arsenic modulates constitutive IKK/NF-B activity in HRS cells, and whether IKK/NF-B inhibition contributes to arsenic induced apoptosis. We report that sodium arsenite (NaAsO 2 ) and arsenic trioxide (As 2 O 3 ) strongly inhibit constitutive IKK and NF-B activity in HRS cell lines and down-regulate NF-B dependent target genes, among these TRAF1, c-IAP2, IL-13 and CCR7. In these cell line models, inhibition of constitutively active NF-B correlates with arsenic induced apoptosis.
That NF-B inhibition is indeed involved in apoptosis induction by arsenic is directly shown by overexpression of NF-B-p65, which rescues HRS cells from arsenic induced apoptosis. In a NOD/SCID mouse model, arsenic trioxide down-regulates NF-B and induces a dramatic response in L540Cy xenotransplated Hodgkin tumor cells, confirming the in vitro data. Northern blot analysis. Total RNA was prepared using the RNeasy kit (QIAGEN, Hilden, Germany). 10 µg of total RNA were subjected to gel electrophoresis on a 1.1% formaldehyde-1.2% agarose gel and transferred to a nylon membrane (Appligene, Heidelberg, Germany).
After UV cross-linking, the membrane was prehybridized ( and two mice were treated with 7.5 mg/kg As 2 O 3 . After six hours, the mice were sacrificed.
The tumors were explanted and whole cell extracts of the tumor material were prepared. In the second experiment, 10 7 L540Cy or HD-MyZ cells were inoculated subcutaneously. Mice 9 were divided into three groups, when tumors were palpable. Group 1 (n=6) was treated i.v.
with PBS alone, group 2 (n=6) received 5 mg/kg/d, and group 3 (n=6) 7.5 mg/kg/d As 2 O 3 i.v.
The in vitro analysis of tumor cells was as described above. Indeed, incubation of HRS cells with both high and low concentrations of NaAsO 2 reduced IKK activity, as measured by in vitro kinase assays (Fig. 1C) . In contrast, all three groups of MAPKs (ERK1/2, p38 and JNK) were activated by arsenite (data not shown). We therefore analyzed the role of caspase-8, which plays a major role in this process, in arsenite mediated apoptosis (Fig. 2D) (Fig. 3A) . In addition, CCR7 and IL-13, which are both strongly expressed in HRS cells and newly identified NF-B dependent target genes 32,34 , showed a down-regulation of their respective mRNAs (Fig. 3B) . We investigated the response of representative HRS cell lines towards 2, 5 and 10 µM arsenite (Fig. 4) . A dose dependent induction of apoptosis was detectable in the cell lines HDLM-2 and L540 ( Fig. 4A; see above) . Only weak induction of apoptosis was observed in the cell line KMH-2 (15%), whereas L428 and HD-MyZ cells were resistant to arsenite induced apoptosis. In contrast to the decrease of the constitutive NF-B activity in the arsenite Whole cell extracts were analyzed by EMSA for NF-B DNA binding activity. Free DNA probe is not shown, n.s., non specific. 
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Remission of xenotransplanted Hodgkin tumors in NOD/SCID mice after treatment with arsenic trioxide. Arsenic trioxide (As 2 O 3 ), in contrast to arsenite, is used in clinical studies. In vitro, both substances behaved similarly regarding the inhibition of NF-B and induction of apoptosis, even though As 2 O 3 showed stronger biological effects than NaAsO 2 ( Fig. 6A and data not shown) . We investigated the in vivo activity of As 2 O 3 on xenotransplanted Hodgkin tumor cells (Fig. 6B) . In a first experiment, NOD/SCID mice were subcutaneously transplanted with the HRS cell line L540Cy. Mice with palpable tumors were treated on days 3 -17 with 3.75 mg/kg As 2 O 3 i.v. Only a slight, non-significant growth retardation was observed. We therefore decided to continue the treatment with 7.5 mg/kg i.v.
daily. Surprisingly, two days of treatment with 7.5 mg/kg As 2 O 3 were sufficient to induce a complete remission of the Hodgkin tumors. The treatment was continued for another 6 days (days 20 -25). Animals of the As 2 O 3 treated group remained in complete remission for 10 days, thereafter, tumor regrowth was observed (not shown). To validate these data, a second experiment with the arsenic sensitive cell line L540Cy (Fig. 6C ) as well as with the resistant cell line HD-MyZ (Fig. 6D ) was performed. Beginning on day 8, mice of both groups were left untreated or treated with 5 or 7.5 mg/kg/d As 2 O 3 i.v. Again, a dose-dependent strong response, although no complete remission, was observed for the L540Cy tumors. In contrast, HD-MyZ cells were, as shown in vitro, also in vivo clearly less responsive to the application of As 2 O 3 . Importantly, EMSA analysis of explanted tumor cells after in vivo application of 7.5 mg/kg As 2 O 3 revealed strong inhibition of constitutive NF-B activity in L540Cy (Fig. 6C ), but not in HD-MyZ cells (Fig. 6D) . In the first experiment, one mouse died at day 21, in the second experiment, two mice of the 7.5 mg/kg/d treated group died after 3 weeks of treatment. All other animals showed no relevant signs of toxicity; the body weight decreased in arsenic treated mice between 3 -7%. (Fig. 4) . In two of them, L428 and KMH-2, I B proteins are functionally inactive. Thus, the arsenite induced down-regulation of NF-B, which requires intact I B proteins, is inhibited. In comparison to the other cell lines investigated, only very weak constitutive IKK/NF-B activity was detectable in HD-MyZ cells (Table 1) . These data indicated a correlation between arsenic mediated apoptosis and inhibition of IKK/NF-B activity. To directly examine a causal relationship, L540Cy cells were transfected with NF-B-p65 expression constructs, resulting in rescue from arsenic induced apoptosis (Fig. 5) . We Fig. 2) . The down-regulation of NF-B dependent antiapoptotic genes (see above), which can thus no longer function to inhibit caspase-8, therefore appears to be an important regulatory step of arsenite induced apoptosis in HRS cells.
Taken together, our data indicate that inhibition of NF-B contributes to the cytotoxic action of arsenic. Although a number of the experiments was performed with concentrations of arsenic which are higher than those achievable in patients (0.5 -5 µM), most of the data were validated also for low concentrations of arsenic. Increased NF-B activity has been recognized as an important mechanism leading to drug-resistance in tumor cells 48 , and 
